123 related articles for article (PubMed ID: 9610080)
1. Magnitude of lipoprotein (a) in diabetes mellitus.
Khan MA; Baseer A
J Pak Med Assoc; 1998 Jan; 48(1):11-3. PubMed ID: 9610080
[TBL] [Abstract][Full Text] [Related]
2. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) status in coronary heart disease.
Khan MA; Baseer A
J Pak Med Assoc; 2000 Feb; 50(2):47-50. PubMed ID: 10769521
[TBL] [Abstract][Full Text] [Related]
4. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
Ferlito S; Gallina M
Panminerva Med; 1998 Dec; 40(4):304-8. PubMed ID: 9973826
[TBL] [Abstract][Full Text] [Related]
5. Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study.
Siegel RD; Cupples A; Schaefer EJ; Wilson PW
Metabolism; 1996 Oct; 45(10):1267-72. PubMed ID: 8843183
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein (a) and other risk factors in children with insulin-dependent diabetes mellitus and children without diabetes.
Martinez MT; Ramos O; Carretero N; Calvillan M; Gutierrez-Lopez MD; Cuesta P; Serrano-Rios M
Diabete Metab; 1994; 20(6):522-5. PubMed ID: 7713274
[TBL] [Abstract][Full Text] [Related]
7. Nitrite plasma levels in type 1 and 2 diabetics with and without complications.
Ferlito S; Gallina M
Minerva Endocrinol; 1999; 24(3-4):117-21. PubMed ID: 10953727
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein profile in type II diabetic patients with and without coronary heart disease.
Barbagallo CM; Averna MR; Amato S; Marino G; Labisi M; Rao AC; Barbagallo M; Cupidi GF; Notarbartolo A
Acta Diabetol Lat; 1990; 27(4):371-7. PubMed ID: 2087939
[TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation and antioxidant enzyme status in Type 2 diabetics with coronary heart disease.
Kesavulu MM; Rao BK; Giri R; Vijaya J; Subramanyam G; Apparao C
Diabetes Res Clin Pract; 2001 Jul; 53(1):33-9. PubMed ID: 11378211
[TBL] [Abstract][Full Text] [Related]
10. Familial aggregation of non-insulin dependent diabetes and coronary heart disease are accompanied by different effects on serum lipids, lipoproteins and apolipoproteins.
Sarlund H; Laakso M; Voutilainen E; Penttilä I; Pyörälä K
Atherosclerosis; 1991 Jan; 86(1):17-29. PubMed ID: 2064632
[TBL] [Abstract][Full Text] [Related]
11. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for coronary heart disease in noninsulin dependent diabetes mellitus (NIDDM).
Thulaseedharan N; Augusti KT
Indian Heart J; 1995; 47(5):471-6. PubMed ID: 8714500
[TBL] [Abstract][Full Text] [Related]
13. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus.
Laakso M; Pyörälä K; Sarlund H; Voutilainen E
Arteriosclerosis; 1986; 6(6):679-84. PubMed ID: 2877651
[TBL] [Abstract][Full Text] [Related]
14. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
[TBL] [Abstract][Full Text] [Related]
15. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan SR; Ayub N; Nawab S; Shamsi TS
J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
[TBL] [Abstract][Full Text] [Related]
16. Effects of glyburide treatment on serum lipoprotein and apolipoprotein concentrations and ratios in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Brunner D
Clin Ther; 1988; 10(4):392-400. PubMed ID: 3152618
[TBL] [Abstract][Full Text] [Related]
17. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
[TBL] [Abstract][Full Text] [Related]
18. Apo B-containing lipoprotein particles in poorly controlled insulin-dependent diabetes.
Igau B; Lestavel S; Clavey V; Slomianny C; Drouin P; Bresson R; Fruchart JC; Duriez P; Fiévet C
Atherosclerosis; 1996 Feb; 120(1-2):209-19. PubMed ID: 8645362
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
20. Lipid and lipoprotein abnormalities in diabetic patients with peripheral vascular disease.
Laakso M; Pyörälä K
Atherosclerosis; 1988 Nov; 74(1-2):55-63. PubMed ID: 3214481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
